Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124195862 | 12419586 | 2 | F | 20160331 | 20160823 | 20160531 | 20160830 | EXP | CA-VIIV HEALTHCARE LIMITED-CA2016GSK075849 | VIIV | 51.75 | YR | M | Y | 69.00000 | KG | 20160830 | PH | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124195862 | 12419586 | 1 | PS | TIVICAY | DOLUTEGRAVIR SODIUM | 1 | Oral | 50 DF, UNK | 204790 | 50 | DF | ||||||||
| 124195862 | 12419586 | 2 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | UNK | 0 | ||||||||||
| 124195862 | 12419586 | 3 | SS | FENTANYL. | FENTANYL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124195862 | 12419586 | 1 | HIV infection |
| 124195862 | 12419586 | 2 | HIV infection |
| 124195862 | 12419586 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124195862 | 12419586 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124195862 | 12419586 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124195862 | 12419586 | 1 | 20160310 | 0 | ||
| 124195862 | 12419586 | 2 | 20160310 | 0 |